Chitayat–Moore–Del Bigio syndrome
Chitayat–Moore–Del Bigio Syndrome is a rare genetic disorder characterized by a range of physical and developmental anomalies. The syndrome was first identified and described by Chitayat, Moore, and Del Bigio, who observed a distinct pattern of clinical features among affected individuals. This condition is notable for its complexity and the variety of symptoms that can present, making it a challenging syndrome to diagnose and manage.
Symptoms and Characteristics[edit | edit source]
The primary features of Chitayat–Moore–Del Bigio Syndrome include developmental delay, neurological abnormalities, and distinctive facial features. Patients may exhibit a delay in reaching developmental milestones, intellectual disability, and various neurological issues such as seizures and hypotonia (reduced muscle tone). The facial characteristics associated with this syndrome can include a prominent forehead, widely spaced eyes (hypertelorism), a flat nasal bridge, and a small jaw (micrognathia).
Genetics[edit | edit source]
Chitayat–Moore–Del Bigio Syndrome is believed to be caused by genetic mutations; however, the specific genetic basis of the syndrome is not fully understood. It is thought to follow an autosomal recessive pattern of inheritance, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Chitayat–Moore–Del Bigio Syndrome is primarily based on clinical observation and the identification of characteristic symptoms. Genetic testing may be utilized to identify specific mutations and confirm the diagnosis, although the rarity of the syndrome and the lack of comprehensive genetic information can make this challenging.
Management and Treatment[edit | edit source]
There is no cure for Chitayat–Moore–Del Bigio Syndrome, and treatment is symptomatic and supportive. Management strategies may include physical therapy, occupational therapy, and speech therapy to help individuals achieve their maximum developmental potential. Medications may be prescribed to manage seizures and other medical issues. Early intervention and a multidisciplinary approach are crucial for improving the quality of life for affected individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Chitayat–Moore–Del Bigio Syndrome varies depending on the severity of symptoms and the presence of associated health issues. With appropriate management and support, individuals with this syndrome can lead fulfilling lives, although they may face significant challenges related to their physical and developmental health.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD